Dr. Nara is one of the co-founders, the Chief Scientific Officer and President Business Development for Keystone Bio Inc. in St. Louis, Mo., a Systemic-Oral Health Biotech with bio-therapeutics fand CDx or the elimination of a specific oral virulent bacterial associated with systemic inflammation. He holds a M.Sc. in Immuno-pharmacology, a combined Doctor of Veterinary Medicine and Ph.D. (retro-virology/oncogenesis) from The Ohio State University, 4 year combined residency in Comparative Pathology and NIH post-doctoral Fellowship at the Armed Forces Institute of Pathology and a NIH. He is also elected Fellow of the American Association for the Advancement of Science in 2011 and distinguished Alumni of The Ohio State University College of Veterinary Medicine 2014